Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    Science & Regulatory
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyScience & RegulatoryAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3167 results found
Expand All
Apply All
3167 results found

BIO Applauds Farm Bill Progress, Calls for 'Innovation-Centric' Bill
Share
Press Release  •  May 2, 2024
BIO commends the leaders and members of the House and Senate Agriculture Committees on their persistence and dedication toward passing a new farm bill this year. The farm bill is vital policy that benefits all Americans, including nutrition programs, conservation incentives and support for agricultural production needed to ensure food security and renewable energy supply chains. The farm bill also includes important provisions to advance innovation and grow the nation’s bioeconomy. BIO-supported provisions to ensure the farm bill is innovation-centric include the following: Funding for the Biobased Markets Program, which directs federal agencies to increase purchases of biobased and renewable products. Updates to North American Industry Classification System (NAICS) codes to enable measurement and growth of biobased procurement. Biorefinery incentives to help build and retrofit facilities to produce the advanced biofuels, renewable chemicals and other biobased products our economy needs. Support for biostimulants by including the Plant Biostimulant Act (H.R. 1472) to streamline regulation of these safe, biological substances to make plants more resilient and productive. Support for Plant Incorporated Protectants (PIPs) with language directing the Environmental Protection Agency to reissue PIPs regulations and eliminate unnecessary and non-science-based barriers to bringing these innovations to market. Streamlined regulation of biotechnology, with a science-based process that allows for timely approvals of innovations in plant, animal and microbial biotech. Increased investment in agricultural research programs to fuel ongoing innovation in agriculture and environmental technology. The bioeconomy plows nearly a trillion dollars annually, and growing, into the U.S. economy, which benefits all Americans. “Congress has an unprecedented opportunity with this farm bill to enable continued biotech breakthroughs to ensure we can meet the world’s…
Read More

BIO Finance & Tax Committee Meeting
Share
May 2, 2024
The Committee concentrates on tax, financial services, securities, and accounting policies that impact member companies and biotech capital formation. This committee advises BIO staff about the impact of legislation and regulations affecting these policy matters and supports BIO’s engagement with Treasury, the SEC, and the IRS, as well as Congress and the Administration. For more information and to join the Committee, please contact Emily Berst (eberst@bio.org).
Read More

Toolkit for Advocates
Share

Lawmakers speak out on AAPs
Share
Good Day BIO Newsletter  •  May 2, 2024
Arizona Gov. Hobbs recently vetoed an anti-science bill against animal vaccines, and a group of 26 bipartisan Members of Congress are speaking out against copay accumulator adjustment programs (AAPs). (638 words, 3 minutes, 11 seconds)
Read More

BIO Webinar: BIO 2024 Advanced Partnering & Know Before You Go
Share
May 1, 2024
This webinar will help BIO 2024 attendees/exhibitors better prepare for their onsite experience at the event. We will provide important and practical onsite information, as well as provide further instruction on how to more effectively use advanced features of the BIO One-on-One Partnering™ system. Attend this webinar—led by BIO’s VP of Partnering and BIO’s Manager of Exhibit Sales & Systems—to gain valuable insights to make the most out of your participation at the upcoming BIO International Convention in San Diego this June! Speakers: Mackensie Vernetti, Vice President, Partnering, BIO Sydney Williams, Manager, Exhibit Sales & Systems, BIO
Read More

SAF tax credits, VBPs, and BIO in Paris
Share
Good Day BIO Newsletter  •  May 1, 2024
A newsy Wednesday: Treasury and the IRS released updated SAF tax credit guidance, a new bill would facilitate value-based drug payments, and a BIO delegation to Paris highlighted Franco-American biotech cooperation. (767 words, 3 minutes, 50 seconds)
Read More

BIO Statement Re Updated GREET Model to Measure Lifecycle Emissions from Sustainable Aviation Fuels
Share
Press Release  •  April 30, 2024
The following statement may be attributed to Beth Ellikidis, BIO's Vice President for Agriculture & Environment: “Today’s release of an updated methodology to qualify crop-based sustainable aviation fuel (SAF) for federal tax credits is a positive step toward meeting the rapidly growing demand for SAF and leveraging agricultural innovation to make air transportation cleaner and greener. “Biotech innovation is a critical tool to help farmers adopt climate-smart agricultural practices to qualify their crops as tax credit-eligible SAF feedstocks, including no-till farming and microbial biofertilizers. BIO’s member companies stand ready to bring to market the innovations needed to reduce the carbon intensity of agriculture and crop-based fuels.”
Read More

Admiral William McRaven to Keynote
2024 BIO Convention
Share
Press Release  •  April 30, 2024
Retired U.S. Navy (SEAL) Four-Star Admiral and the Former Chancellor of The University of Texas System, William McRaven, to Discuss Leadership, Global Events, and the National Security Importance of Biotechnology with BIO CEO, John CrowleyWASHINGTON - (April 30, 2024) – As recent global events have demonstrated, the world has become more challenging and American leadership is needed more at home and abroad than ever before, and that includes maintaining U.S. dominance in biotechnology innovation. Retired U.S. Navy four-star admiral, Navy SEAL, University Chancellor, best-selling author and world-renowned authority of leadership, William McRaven, will keynote the 2024 BIO International Convention, Wednesday, June 5, in San Diego. Admiral McRaven will be interviewed by John Crowley, CEO of the Biotechnology Innovation Organization (BIO) about the challenge of global events today and the implications for biotechnology as a national security imperative. McRaven will also share his insights on essential elements of leadership in managing complex organizations. Over the course of his distinguished military career, McRaven gained first-hand insight into the numerous threats facing the United States. “For more than a century, the United States has been the medicine chest to the world, providing life-saving vaccines, antibiotics, and therapeutics, saving millions of lives. In the face of diverse global threats, maintaining a robust biotech industry is paramount for safeguarding both the nation and our allies,” said McRaven.“We are on the cusp of a golden age of biotechnology, and Admiral McRaven will highlight why it is a strategic imperative for the United States to bolster our biotechnology capabilities and foster innovation in order to safeguard our nation and global society,” said Crowley. “He brings unparalleled expertise and experience to the discussion on the intersection of biotechnology and national security.” Listed as one of the world’s greatest leaders…
Read More

Admiral McRaven to keynote BIO 2024
Share
Good Day BIO Newsletter  •  April 30, 2024
BIO announced one of the keynote speakers at the 2024 BIO International Convention: Admiral William McRaven. Plus, Sen. Sanders launched a politically motivated investigation into revolutionary, cost-effective diabetes and obesity medicines—BIO explains what you need to know. (634 words, 3 minutes, 10 seconds)
Read More

Limb loss advocates highlight progress
Share
Good Day BIO Newsletter  •  April 29, 2024
Today we highlight April’s Limb Loss and Limb Difference Awareness Month and the economic impact of sustainable aviation fuel. (538 words, 2 minutes, 41 seconds)
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 53
  • 54
  • 55
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Investment and Growth Summit
BIO Partnering™ for Oncology
BIO International Convention
BIO Partnering™ at JPM Week
BIO Patient Advocacy Changemakers Events
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO